1
|
Antiviral effect of HPMPC (Cidofovir®), entrapped in cationic liposomes: In vitro study on MDBK cell and BHV-1 virus. J Control Release 2012; 160:330-8. [DOI: 10.1016/j.jconrel.2012.01.040] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2011] [Revised: 01/25/2012] [Accepted: 01/27/2012] [Indexed: 11/19/2022]
|
2
|
Pertusat F, Serpi M, McGuigan C. Medicinal Chemistry of Nucleoside Phosphonate Prodrugs for Antiviral Therapy. ACTA ACUST UNITED AC 2012; 22:181-203. [DOI: 10.3851/imp2012] [Citation(s) in RCA: 73] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/23/2011] [Indexed: 10/15/2022]
Abstract
Considerable attention has been focused on the development of phosphonate-containing drugs for application in many therapeutic areas. However, phosphonate diacids are deprotonated at physiological pH and thus phosphonate-containing drugs are not ideal for oral administration, an extremely desirable requisite for the treatment of chronic diseases. To overcome this limitation several prodrug structures of biologically active phosphonate analogues have been developed. The rationale behind the design of such agents is to achieve temporary blockade of the free phosphonic functional group until their systemic absorption and delivery, allowing the release of the active drug only once at the target. In this paper, an overview of acyclic and cyclic nucleoside phosphonate prodrugs, designed as antiviral agents, is presented.
Collapse
Affiliation(s)
| | - Michaela Serpi
- Welsh School of Pharmacy, Cardiff University, Cardiff, UK
| | | |
Collapse
|